
USFDA APPLICATION NUMBER - 20699 / DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| VENLAFAXINE HYDROCHLORIDE(UNII: 7D7RX5A8MO) (VENLAFAXINE - UNII:GRZ5RCB1QG) | VENLAFAXINE | 150mg |
Inactive Ingredients
| Ingredient Name | Aphena Pharma Solutions - Tennessee, Inc. | Apotex Corp. | Bryant Ranch Prepack | Cardinal Health | Clinical Solutions Wholesale | Greenstone LLC | Lake Erie Medical DBA Quality Care Products LLC | PD-Rx Pharmaceuticals, Inc. | Preferred Pharmaceuticals, Inc. | REMEDYREPACK INC. | Unit Dose Services | REMEDYREPACK INC. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ETHYLCELLULOSE (100 MPA.S)(47MLB0F1MV) | ||||||||||||
| FERRIC OXIDE RED(1K09F3G675) | ||||||||||||
| GELATIN(2G86QN327L) | ||||||||||||
| GELATIN, UNSPECIFIED(2G86QN327L) | ||||||||||||
| HYPROMELLOSE 2910 (6 MPA.S)(0WZ8WG20P6) | ||||||||||||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | ||||||||||||
| HYPROMELLOSES(3NXW29V3WO) | ||||||||||||
| POWDERED CELLULOSE(SMD1X3XO9M) | ||||||||||||
| TITANIUM DIOXIDE(15FIX9V2JP) |